TXN TEXAS INSTRUMENTS INC
Semiconductors & Related Devices · Nasdaq · SEC CIK 97476 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY20.3%
TTM net income YoY41.0%
TTM EPS YoY40.4%
Revenue 3-yr CAGR4.7%
Net income 3-yr CAGR0.1%
Margins
Gross margin60.2%
Operating margin40.8%
Net margin34.3%
FCF margin35.2%
EBITDA margin51.3%
Returns
ROE39.7%
ROA19.8%
ROIC (approx.)26.5%
Asset turnover0.58x
Leverage & solvency
Liabilities / assets47.9%
Debt / equity0.71x
Current ratio5.59x
Interest coverage15.01x
Cash quality & payout
Operating cash flow / net income1.39x
Accruals ratio-7.7%
Payout ratio72.7%
Capex / revenue12.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $17.68B | $15.64B |
| Cost of revenue | $7.60B | $6.55B |
| Gross profit | $10.08B | $9.09B |
| R&D expense | $2.08B | $1.96B |
| SG&A expense | $1.86B | $1.79B |
| Operating income | $6.02B | $5.46B |
| Interest expense | $543.00M | $508.00M |
| Pretax income | $5.71B | $5.45B |
| Income tax | $709.00M | $654.00M |
| Net income | $5.00B | $4.80B |
| EBITDA | $7.94B | $6.97B |
| EPS (basic) | 5.47 | 5.24 |
| EPS (diluted) | 5.45 | 5.20 |
| Dividends declared per share | 5.50 | 5.26 |
| Weighted avg. shares (diluted) | 913.00M | 919.00M |
| Balance sheet | ||
| Cash & equivalents | $3.23B | $3.20B |
| Short-term investments | $1.66B | $4.38B |
| Receivables | $1.96B | $1.72B |
| Inventory | $4.80B | $4.53B |
| Current assets | $13.75B | $15.03B |
| PP&E, net | $12.32B | $11.35B |
| Goodwill | $4.33B | $4.36B |
| Intangibles | $238.00M | — |
| Total assets | $34.59B | $35.51B |
| Current liabilities | $3.16B | $3.64B |
| Short-term debt | $500.00M | $750.00M |
| Long-term debt | $13.55B | $12.85B |
| Total debt | $14.05B | $13.60B |
| Total liabilities | $18.31B | $18.61B |
| Shareholders' equity | $16.27B | $16.90B |
| Net debt | $10.82B | $10.40B |
| Cash flow statement | ||
| Operating cash flow | $7.15B | $6.32B |
| Capital expenditure | $4.55B | $4.82B |
| Free cash flow | $2.60B | $1.50B |
| Investing cash flow | -$1.44B | -$3.20B |
| Financing cash flow | -$5.69B | -$2.88B |
| Depreciation & amortization | $1.92B | $1.51B |
| Stock-based compensation | $419.00M | $387.00M |
| Dividends paid | $5.00B | $4.79B |
| Share buybacks | $1.48B | $929.00M |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.